Egetis Therapeutics Announces Annual General Meeting

• Egetis Therapeutics will hold its annual general meeting on May 12, 2027.
• Proposals will cover board appointments and remuneration, as well as auditor appointment and compensation.
• Shareholders will also consider the process for appointing the nomination committee for the 2028 annual general meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Egetis Therapeutics AB (publ) published the original content used to generate this news brief on October 21, 2026, and is solely responsible for the information contained therein.